Clinical Trial

Training for Urinary Leakage Improvement After Pregnancy

Study acronym: TULIP
Recruiting
View on ClinicalTrials.gov →
Summary
This is a multi-center, randomized single-blind nonsurgical trial conducted in approximately 216 primiparous postpartum women at high risk for prolonged/sustained pelvic floor disorders with symptomatic, bothersome urinary incontinence (UI) amenable to nonsurgical treatment. TULIP is a 3-Arm trial with two active interventions (Arms 1 and 2) and a Patient Education control arm (Arm 3). Arm 1 consists of pelvic floor muscle training (PFMT). Arm 2 uses a home biofeedback device (leva®). The primary outcome will be assessed at 6 months postpartum by blinded outcomes assessors, and follow-up will continue until 12 months postpartum.
Protocol Amendment History 5 amendments
This ClinicalTrials.gov record has been amended 5 times since 2024-05-07; most recent amendment 2025-12-29.
Status change: Not Yet Recruiting → Recruiting 2024-11-13
Trial Details
NCT Number NCT06411158
Lead Sponsor NICHD Pelvic Floor Disorders Network
Collaborators: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), Duke University, Kaiser Permanente, University of California, San Diego, University of Chicago, University of Pennsylvania, University of Texas Southwestern Medical Center, Women and Infants Hospital of Rhode Island, RTI International
Conditions Urinary Incontinence, Delivery Complication
Enrollment 216 participants
Start Date 2024-11-12
Primary Completion 2027-05-12 (estimated)
Study Completion 2027-11-12 (estimated)
Updated on ClinicalTrials.gov 2025-12-31